Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Franchi Jean M.

SEC-identified person · CIK 1653053 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Gemini Therapeutics, Inc. /DE IRON Chief Financial Officer filed 2024–2026
Biodesix INC BDSX Director filed 2020–2026
Replimune Group, Inc. REPL Chief Financial Officer filed 2019–2023
Merrimack Pharmaceuticals INC MACK Chief Financial Officer filed 2017–2018
Dimension Therapeutics, Inc. DMTX Chief Financial Officer filed 2015–2017

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.